ABUS vs BIIB: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Biogen Inc in 2026
ABUS
Arbutus Biopharma Corp
—
BIIB
Biogen Inc
$199.15
Key Metrics Comparison
| Metric | ABUS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $29.33B | BIIB |
| P/E Ratio | 5.39 | 21.39 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or BIIB a better investment?
Comparing ABUS and BIIB: Arbutus Biopharma Corp has a market cap of $882.99M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and BIIB?
ABUS (Arbutus Biopharma Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or BIIB?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 21.4x).
Which is growing faster: ABUS or BIIB?
Both ABUS and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $882.99M for ABUS.
Should I buy ABUS or BIIB in 2026?
Both ABUS and BIIB have investment merit. ABUS trades at $N/A while BIIB trades at $199.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and BIIB stock?
Key differences: Market Cap ($882.99M vs $29.33B), P/E Ratio (5.4x vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or BIIB in 2026?
The choice between ABUS and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and BIIB?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.